Patient P-02570

Synthetic patientMETA-24 · Day 175 · 55–64 · F · baseline S15Steering view · 3D Open companion preview

Therapy response

Unstable

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

45%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S15
Day 17 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 17.

Primary contributors, last 14 days

GI instability+14
Treatment adherence-8
Nutritional resilience-7
Inflammatory activity+6
Toxicity-4

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

64 min

improving · +2.4 vs previous 14 d

Sleep duration

Wearable

7.7 h

stable · -0.1 vs previous 14 d

Energy level

Daily log

4.4/10

worsening · -0.4 vs previous 14 d

Steps

Wearable

6,386

stable · +245 vs previous 14 d

GI burden

Companion

37.7/100

worsening · +4.8 vs previous 14 d

Adherence

Companion

79.8 %

stable · +1.8 vs previous 14 d

Sleep quality

Wearable

61.4/100

stable · -1.0 vs previous 14 d

Glucose, CGM daily mean

CGM

136 mg/dL

stable · +2.6 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 49 from the failing basin, 62 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.8 next day on high-intake days · n 22

Would not help

BR-03 Behavioural Recommendation
only 27% improved among 11 similar
Keep alcohol low
GI +5.8 next day on high-intake days · n 19

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+5.8detractor · 95%
Protein
-5.8supporter · 95%
Simple carbohydrates
-1.1no signal · 22%
Histamine load
-0.4no signal · 15%
Insoluble fibre
-0.3no signal · 15%
Ultra-processed food
+0.2no signal · 15%
Caffeine
-0.1no signal · 15%
Dietary fat load
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.6 · butyrate capacity 50/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 67 ms
Sleep: 7.4 h
Steps: 6,543
Resting HR: 61 bpm

Daily log: GI score 38, nutritional resilience 52, adherence 80.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02552	33%	S07	AD-05	no change	29
P-02093	31%	S05	AD-05	no change	40
P-02285	29%	S14	AD-05	no change	39
P-02031	27%	S12	AD-05	improved	47
P-02308	36%	S13	BR-03	no change	27
P-02564	35%	S15	BR-03	improved	32
P-02522	34%	S01	BR-03	no change	40
P-02087	32%	S01	BR-03	no change	40
P-02331	32%	S14	BR-03	improved	34
P-02439	30%	S08	BR-03	no change	40
P-02325	29%	S19	BR-03	no change	33
P-02638	27%	S01	BR-03	improved	41